Salinomycin also suppresses the expression of the ATP-binding cassette transporter in multidrug-resistant cells and interferes with key signaling pathways involved in cell survival and cancer progression (PI3K/Akt, Wnt/β-catenin, Hedgehog, Notch) [47,50]. Here, AKT1 is linked to cancer.